Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine

Vaccine

Volumn 27, Issue 37, 2009, Pages 5096-5102

  Kitchin, Nicholas ^a   Southern, Joanna ^b   Morris, Rhonwen ^b   Borrow, Ray ^b   Fiquet, Anne ^c   Boisnard, Florence ^c   Thomas, Stéphane ^c   Miller, Elizabeth ^b  

^a Sanofi Pasteur MSD Ltd   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c SANOFI PASTEUR   (France)

Author keywords

Acellular pertussis combination vaccine; Immunogenicity and safety; Pre school booster

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PEDIACEL; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFLUENZA; MEASLES; MENINGOCOCCOSIS; MUMPS; NORMAL HUMAN; OPEN STUDY; PERTUSSIS; POLIOMYELITIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RUBELLA; TETANUS; UNITED KINGDOM;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; GREAT BRITAIN; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; MENINGOCOCCAL VACCINES; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; VACCINES, COMBINED; VACCINES, CONJUGATE;

EID: 67651014413     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.049     Document Type: Article

References (17)

1. Edwards K.M., Bradley R.B., Decker M.D., Palmer P.S., Van Savage J., Taylor J.C., et al. Evaluation of a new highly purified pertussis vaccine in infants and children. J Infect Dis 160 (1989) 832-837
2. Bernstein D.I., Smith V.E., Schiff G.M., Rathfon H.M., and Boscia J.A. Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age. Pediatr Infect Dis J 12 (1993) 131-135
3. Halperin S.A., Eastwood B.J., Barreto L., Friesen B., Medd L., Meekison W., et al. Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine 14 (1996) 767-772
4. Terry L. The association of cases of poliomyelitis with the use of type 3 oral poliomyelitis vaccines (1962), US Department of Health, Education and Welfare, Washington, DC
5. Kitchin N.R.E., Southern J., Morris R., Hemme F., Thomas S., Watson M.W., et al. Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age. Arch Dis Child 92 (2007) 11-16
6. Kitchin N., Southern J., Morris R., Hemme F., Cartwright K., Watson M., et al. A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age. Vaccine 24 (2006) 3964-3970
7. Department of Health. PL CMO (2003) 1: Planned HIB vaccination catch-up campaign. Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Pr ofessionalletters/Chiefmedicalofficerletters/DH_4004814 (accessed 23 December 2008).
8. Trotter C.L., Andrews N.J., Kaczmarski E.B., Miller E., and Ramsay M.E. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364 (2004) 365-367
9. Borrow R., and Miller E. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned. Expert Rev Vaccines 5 (2006) 851-857
10. Makwana N., and Riordan F.A. Bacterial meningitis: the impact of vaccination. CNS Drugs 21 (2007) 355-366
11. Department of Health. Pneumococcal vaccine launch - Department of Health press release, 2006/0293. August 2006. Available at: http://www.immunisation.nhs.uk/Library/News/Pneumococcal_vaccine_launch_ -_Department_of_Health_press_release.(accessed 23 December 2008).
12. Burrage M., Robinson A., Borrow R., Andrews N., Southern J., Findlow J., et al. Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect Immun 70 (2002) 4946-4954
13. Collins C.L., Salt P., McCarthy N., Chantler T., Lane L., Hemme F., et al. Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children. Vaccine 22 (2004) 4262-4269
14. Halperin S.A., Scheifele D., Barreto L., Pim C., Guasparini R., Medd L., et al. Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J 18 (1999) 772-779
15. Mascart F., Hainaut M., Peltier A., Verscheure V., Levy J., and Locht C. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 25 (2007) 391-398
16. Rowe J., Yerkovich S.T., Richmond P., Suriyaarachchi D., Fisher E., Feddema L., et al. Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children. Infect Immun 73 (2005) 8130-8135
17. Rothstein E.P., Bernstein H.H., Glode M.P., Laussucq S., Nonenmacher J., Long S.S., et al. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines. Am J Dis Child 147 (1993) 854-857